The many faces of Orai1 dysfunction: Molecular mechanisms and clinical manifestations
Journal of General Physiology · 2026
DOI: 10.1085/jgp.202614031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of General Physiology, 2026. Verfasst von Magdalena Prantl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biophysics, JKU Life Science Center, Johannes Kepler University Linz , Linz, Austria. Hauptthemen laut MEDLINE: ORAI1 Protein. Die Arbeit nennt 160 Literaturangaben. Gefördert von: Austrian Science Fund, Resource for Biocomputing, Visualization, and Informatics, University of California, San Francisco.
Abstract (Originalsprache)
Orai1, the pore-forming subunit of the calcium (Ca2+) release-activated Ca2+ (CRAC) channel, plays a central role in store-operated Ca2+ entry (SOCE) in animal cells and thereby serves as a key regulator of intracellular Ca2+ homeostasis. Disruption of this tightly controlled process is associated with a wide spectrum of human diseases. Dysfunction can result from a multitude of remodeling mechanisms, including altered protein expression (up- or downregulation), assembly remodeling, or mutations. We focus in particular on Orai1 mutations, which have been linked to severe combined immunodeficiency (SCID) as a result of channel loss-of-function (LoF), as well as to disorders like tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK) arising from gain-of-function (GoF) alterations. These mutation-induced functional defects can be attributed to a wide variety of disruptions in the complex activation cascade of the Orai1 channel. Under physiological conditions, Orai1 activation involves all four transmembrane (TM) domains and follows a sophisticated interaction mechanism that ensures accurate signal transmission from the protein periphery toward its central Ca2+-conducting pore. In this Review, we compile all currently known disease-associated Orai1 mutations, delineate the mechanisms by which they interfere with the activation cascade, and discuss their pathological relevance. Their widespread distribution across all the domains of this Ca2+ channel highlights that malfunctions at virtually any point along the Orai1 TM domain interfaces can profoundly impair its activation mechanism, ultimately leading to severe diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biophysics, JKU Life Science Center, Johannes Kepler University Linz , Linz, Austria.
ORCID-Profile: Magdalena Prantl, Lara Atzgerstorfer, Tamara Radiskovic, Marc Fahrner, Isabella Derler
Förderung
- Austrian Science Fund
- Resource for Biocomputing, Visualization, and Informatics
- University of California, San Francisco
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Prantl, M., Atzgerstorfer, L., Radiskovic, T., Fahrner, M., & Derler, I. (2026). The many faces of Orai1 dysfunction: Molecular mechanisms and clinical manifestations. Journal of General Physiology. https://doi.org/10.1085/jgp.202614031
Vancouver
Prantl M, Atzgerstorfer L, Radiskovic T, Fahrner M, Derler I. The many faces of Orai1 dysfunction: Molecular mechanisms and clinical manifestations. Journal of General Physiology. 2026. doi:10.1085/jgp.202614031
BibTeX
@article{Prantl2026,
author = {Prantl, Magdalena and Atzgerstorfer, Lara and Radiskovic, Tamara and Fahrner, Marc and Derler, Isabella},
title = {The many faces of Orai1 dysfunction: Molecular mechanisms and clinical manifestations},
journal = {Journal of General Physiology},
year = {2026},
doi = {10.1085/jgp.202614031}
}
EUVIMED